ERA Banner
Download Add to Cart Share
More Like This
  • http://hdl.handle.net/10402/era.25315
  • Pharmacogenomics of Sulfonylureas and Glinides on ATP-Sensitive Potassium Channel
  • Lang, Yiqiao Veronica
  • English
  • Pharmacogenomics
    Sulfonylureas and Glinides
    ATP-Sensitive Potassium Channel
    Type 2 Diabetes
  • Jan 30, 2012 9:36 AM
  • Thesis
  • English
  • Adobe PDF
  • 2685236 bytes
  • The common ATP-sensitive (KATP) channel variants E23K and S1369A, found in the KCNJ11 and ABCC8 genes respectively, form a haplotype that is associated with an increased risk for type 2 diabetes. Our previous studies showed that KATP channel inhibition by the A-site sulfonylurea gliclazide was increased in the K23/A1369 haplotype. Therefore, I studied the pharmacogenomics of eight more clinically used sulfonylureas and glinides to determine their structure activity relationships in KATP channels containing either the E23/S1369 non-risk or K23/A1369 risk haplotypes by utilizing patch-clamp technique. The results demonstrate that the ring-fused pyrrole moiety in several A-site drugs likely underlies the observed inhibitory potency of these drugs on KATP channels containing the K23/A1369 risk haplotype. It may, therefore, be possible to tailor existing therapies or design novel drugs that display increased efficacy in type 2 diabetes patients homozygous for these common KATP channel haplotypes.
  • Master's
  • Master of Science
  • Department of Pharmacology
  • Spring 2012
  • Light, Peter E. (Pharmacology)
  • Tse, Amy (Pharmacology)
    Chan, Cathy (Agricultural, Food & Nutritional Science)
    Simpson, Scot (Pharmacy and Pharmaceutical Sciences)